Table of Contents

• H T Westerveld,
• J C de Graaf,
• H H van Breugel,
• J W Akkerman,
• J J Sixma,
• D W Erkelens,
• and J D Banga

Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.

• P J Beisswenger,
• L L Moore,
• and T J Curphey

Relationship between glycemic control and collagen-linked advanced glycosylation end products in type I diabetes.

• F J Schmidt,
• W J Sluiter,
• and A J Schoonen

Glucose concentration in subcutaneous extracellular space.

• S R Ferreira,
• L J Franco,
• M A Vivolo,
• C A Negrato,
• A C Simoes,
• and C R Ventureli

Population-based incidence of IDDM in the state of São Paulo, Brazil.

• D L Gray,
• C D Langefeld,
• M P Golden,
• and D P Orr

Impact of resident participation in a multidisciplinary diabetes team.

• Y Liao,
• R S Cooper,
• J K Ghali,
• D Lansky,
• G Cao,
• and J Lee

Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease.

• R L Street, Jr,
• V K Piziak,
• W S Carpentier,
• J Herzog,
• J Hejl,
• G Skinner,
• and L McLellan

Provider-patient communication and metabolic control.

• C Tsigos,
• P Reed,
• C Weinkove,
• A White,
• and R J Young

Plasma norepinephrine in sensory diabetic polyneuropathy.

• G Boden,
• X Chen,
• R A DeSantis,
• and Z Kendrick

Effects of age and body fat on insulin resistance in healthy men.

• R E Ringel,
• S A Chalew,
• K A Armour,
• J McLaughlin,
• R J McCarter, Jr,
• and W E Kramer

Cardiovascular reflex abnormalities in children and adolescents with diabetes mellitus.

• G Velho,
• D Erlich,
• E Turpin,
• D Néel,
• D Cohen,
• P Froguel,
• and P Passa

Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM.

• E L Harris,
• S Feldman,
• C R Robinson,
• S Sherman,
• and A Georgopoulos

Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM.

• R E Maser,
• D Usher,
• D J Becker,
• A L Drash,
• L H Kuller,
• and T J Orchard

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.

• C Siebert,
• L F Lipsett,
• J Greenblatt,
• and R E Silverman

Survey of physician practice behaviors related to diabetes mellitus in the U.S. I. Design and methods.

• M Tuttleman,
• L Lipsett,
• and M I Harris

Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients.

• G Sundkvist and
• B Lilja

Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM.

• T Kobayashi,
• K Tamemoto,
• K Nakanishi,
• N Kato,
• M Okubo,
• H Kajio,
• T Sugimoto,
• T Murase,
• and K Kosaka

Immunogenetic and clinical characterization of slowly progressive IDDM.

• N Passariello,
• J Sepe,
• G Marrazzo,
• A De Cicco,
• A Peluso,
• M C Pisano,
• S Sgambato,
• P Tesauro,
• and F D'Onofrio

Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.

Lack of regional variation in IDDM risk in Japan. Japan IDDM Epidemiology Study Group.

• R Bousquet-Rouaud,
• F Castex,
• G Costalat,
• M Bastide,
• B Hedon,
• M Bouanani,
• S Jouvert,
• and J Mirouze

Factors involved in catheter obstruction during long-term peritoneal insulin infusion.

• G Roglic and
• Z Metelko

Effect of war on glycemic control in type II diabetic patients.

• J A Amado,
• E Salas,
• M A Botana,
• J J Poveda,
• and J R Berrazueta

Low levels of intraplatelet cGMP in IDDM.

• J M Newman,
• W H Herman,
• and F Vinicor

Alternative approaches to public health surveillance of IDDM.

• W H Herman,
• D E Prior,
• M D Yassine,
• and A B Weder

Nephropathy in NIDDM is associated with cellular markers for hypertension.

• F R Heller,
• J Jamart,
• P Honore,
• G Derue,
• V Novik,
• L Galanti,
• A Parfonry,
• J C Hondekijn,
• and M Buysschaert

Serum lipoprotein(a) in patients with diabetes mellitus.

• M Matsushima,
• N Tajima,
• T Agata,
• J Yokoyama,
• Y Ikeda,
• and Y Isogai

Social and economic impact on youth-onset diabetes in Japan.

Detection and management of lipid disorders in diabetes. American Diabetes Association.

• S M Haffner

Lipoprotein(a) and diabetes. An update.

• I Libman,
• T Songer,
• and R LaPorte

How many people in the U.S. have IDDM?

• H S Warshaw

Nutrition management of diabetes must be individualized.

• N J Wareham

Cost-effectiveness of alternative methods for diabetic retinopathy screening.

• B S Raheja,
• S M Sadikot,
• R B Phatak,
• and M B Rao

Prevalence of diabetes in Asian Indians.

• K Nagashima,
• S Yutani,
• H Miyake,
• K Onigata,
• H Yagi,
• and T Kuroume

Lipoprotein(a) levels in Japanese children with IDDM.

• B C Hansen and
• N L Bodkin

Standardization of IVGTT. Importance of method used to calculate glucose disappearance.

• R K Bernstein

Depression in adults with diabetes.

• P Kempler,
• A Váradi,
• and G Tamás

Autonomic neuropathy in newly diagnosed diabetes mellitus.

• T Ikeda

Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients.

• J W Pichert and
• M K Antony

Give diabetes more national TV news coverage.

• A Quatraro,
• A Minei,
• G Consoli,
• N De Rosa,
• R Acampora,
• and D Giugliano

Respiratory function in IDDM patients.

• E von Kriegstein,
• H J Wedemeyer,
• and G Storm

More concerns regarding methodology in hypoglycemia study.

• R P Taylor

Questionable accuracy of a filter paper method for measuring GHb.

• K L Ingle

Kahn honored as winner of Banting Medal.

• S L Roberts

Brownlee recipient of Outstanding Scientific Achievement Award.

• K L Ingle

Orchard named 1993 Kelly West recipient.